GNRX

VanEck Vectors Generic Drugs ETF
CLOSING PRICECHANGE (%)VOLUME
$22.54-- (--)1.97K
4:00:00 p.m. (ET) 04/26/2017
BZX EXCHANGE CLOSED
LAST TRADECHANGE (%)
---- (--)
BID SIZEBID ($)ASK ($)ASK SIZE
--------

Overall Rating

N/A

N/A
as of 04/27/17

Rating Details

N/A
N/A
N/A
Segment Average
  • Overview
  • Efficiency
  • Tradability
  • Fit

GNRX Fund Description

The VanEck Vectors Generic Drugs ETF is composed of U.S. and international companies that have a primary business focus on the generic drug industry.

GNRX FactSet Analytics Insight

GNRX is the first ETF to focus specifically onGNRX is the first ETF to focus specifically on generics manufacturers generic drug manufacturers. With more people than ever taking prescription drugs across the globe, the generic drug industry is expected to grow strongly as it provides a lower cost alternative to brand name pharmaceuticals. GNRX’s market cap weighted portfolio is comprised of companies that currently derive or have the potential to derive a significant portion of their revenues from the generic drug industry. The fund casts a wide net to include firms across the size spectrum from both developed and emerging market countries. With respect to fees, GNRX is a little bit pricey but not out of line with similar niche funds.
GNRX’s specific investment thesis is likely to cause a poor fit to our broader pharmaceuticals benchmark. A low Fit score however, should not be considered a negative as it is entirely consistent with the fund’s objective.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

GNRX Top 10 Countries View All

GNRX Top 10 Sectors

GNRX Top 10 Holdings View All

GNRX Summary Data

01/12/16
Open-Ended Fund
0.55%
$4.48 M
$31.72 K
0.80%

GNRX Portfolio Data

$12.69 B
41.15
2.49
0.43%
12/18/17
41

GNRX Index Data

Indxx Global Generics & New Pharma Index
Market Cap
Committee
Thomson Reuters Global Pharmaceuticals

Related ETFs to GNRX

PPH
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

GNRX Portfolio Management

0.55%
--
--
--

GNRX Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

GNRX Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
High
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
------
------
------
------
------
------
------
------
------
------
Bats BZX Real-time Quote - 19:51:40
Average Spread
Premium/Discount
Volume

GNRX FactSet Analytics Block Liquidity

As of 04/27/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of GNRX. GNRX is rated a 1 out of 5.

GNRX Tradability

1,168
$31.72 K
370
$14.7 K
0.80%
$0.18
0.25%
3.50% / -1.84%
None
45.00%
50,000
0.01
0.04%
0.95%
--
$22.54
1

GNRX Performance Statistics

0.40
0.95
-0.53
1.17
0.33%
Thomson Reuters Global Pharmaceuticals